Das; Swadesh K.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Das; Swadesh K..The latest application filed is for "methods and compositions for two-stage microbubble delivery of active agents".

Company Profile

7.6.17

Das; Swadesh K. - Richmond VA
Das; Swadesh K. - Midlothian VA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods and Compositions for Two-Stage Microbubble Delivery of Active Agents App 20220218850 - Fisher; Paul B. ; et al.	2022-07-14
Inhibitors Of Cancer Invasion, Attachment, And/or Metastasis App 20210214365 - FISHER; Paul B. ; et al.	2021-07-15
Compositions Comprising Mda-7/il-24 Protein And Methods Of Use App 20210187071 - FISHER; Paul B. ; et al.	2021-06-24
Recombinant Cancer Therapeutic Cytokine App 20210147502 - Fisher; Paul B. ; et al.	2021-05-20
Inhibitors of cancer invasion, attachment, and/or metastasis Grant 11,008,325 - Fisher , et al. May 18, 2	2021-05-18
Mda-7/il Secretory Variants And Methods Of Use App 20200354745 - Fisher; Paul B. ; et al.	2020-11-12
Inhibitors Of Cancer Invasion, Attachment, And/or Metastasis App 20190263824 - FISHER; Paul B. ; et al.	2019-08-29
Method Of Modulating Survival And Stemness Of Cancer Stem Cells By Mda-9/syntenin (sdcbp) App 20190017054 - FISHER; Paul B. ; et al.	2019-01-17
Tripartite cancer theranostic nucleic acid constructs Grant 10,166,300 - Fisher , et al. J	2019-01-01
Recombinant Cancer Therapeutic Cytokine App 20180305429 - Fisher; Paul B. ; et al.	2018-10-25
PEG-Prom mediated surface expression of avidin/streptavidin Grant 9,994,865 - Fisher , et al. June 12, 2	2018-06-12
Recombinant cancer therapeutic cytokine Grant 9,951,114 - Fisher , et al. April 24, 2	2018-04-24
Use of a truncated CCN1 promoter for cancer diagnostics, therapeutics and theranostics Grant 9,750,823 - Fisher , et al. September 5, 2	2017-09-05
mda-9/syntenin promoter to image and treat metastatic cancer cells Grant 9,701,985 - Fisher , et al. July 11, 2	2017-07-11
Mda-9/syntenin Promoter To Image And Treat Metastatic Cancer Cells App 20160130605 - Fisher; Paul B. ; et al.	2016-05-12
Tripartite Cancer Theranostic Nucleic Acid Constructs App 20160106866 - FISHER; Paul B. ; et al.	2016-04-21
Peg-prom Mediated Surface Expression Of Avidin/streptavidin App 20160108429 - FISHER; Paul B. ; et al.	2016-04-21
Recombinant Cancer Therapeutic Cytokine App 20160108101 - Fisher; Paul B. ; et al.	2016-04-21
Use Of A Truncated Ccn1 Promoter For Cancer Diagnostics, Therapeutics And Theranostics App 20160101193 - Fisher; Paul B. ; et al.	2016-04-14
Diagnostic and Prognostic Markers for Metastasis App 20130338033 - Fisher; Paul B. ; et al.	2013-12-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.